An approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios
This revised roadmap (10 November 2023) replaces the previous version (30 March 2023).
It addresses evolving public health needs as the Omicron variant and its sub-lineages continue to circulate and provides updates for COVID-19 vaccination in relation to simplified vaccine schedules for programmatic use.
The Roadmap will be further adapted should new variants of concern emerge that do not have the characteristics of Omicron, or in the event of significant changes in COVID-19 disease epidemiology, or if significant changes in vaccine attributes warrant an update to the Roadmap.
This document has been updated: Version 10 November 2023.